- Home
- AIRI vs GNTA Comparison
AIRI vs GNTA Comparison
Compare AIRI & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIRI | GNTA |
|---|---|---|
| Founded | 1979 | 2014 |
| Country | United States | Italy |
| Employees | N/A | 13 |
| Industry | Military/Government/Technical | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9M | 19.9M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | AIRI | GNTA |
|---|---|---|
| Price | $3.21 | $0.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 66.2K | 64.1K |
| Earning Date | 05-14-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $47,921,000.00 | N/A |
| Revenue This Year | $6.43 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.55 | $0.59 |
| 52 Week High | $4.17 | $10.00 |
Technical Indicators
Market Signals| Indicator | AIRI | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 48.30 | 42.72 |
| Support Level | $3.18 | $0.71 |
| Resistance Level | $3.38 | $1.70 |
| Average True Range (ATR) | 0.14 | 0.11 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 68.29 | 37.61 |
Price Performance
Historical ComparisonAbout AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.